KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Sep 10, 2026 - 1:51PM >>  ABB India 7311.7  [ -1.10% ]  ACC 1255.1  [ -0.21% ]  Ambuja Cements 395.4  [ -0.16% ]  Asian Paints 2488.7  [ 0.27% ]  Axis Bank 1247.5  [ 0.65% ]  Bajaj Auto 11725  [ -0.59% ]  Bank of Baroda 237.35  [ 1.04% ]  Bharti Airtel 1845.2  [ 1.45% ]  Bharat Heavy 431.5  [ -0.42% ]  Bharat Petroleum 302.9  [ -0.16% ]  Britannia Industries 5019.95  [ -1.56% ]  Cipla 1371.5  [ 0.26% ]  Coal India 433  [ 0.35% ]  Colgate Palm 1805  [ 0.01% ]  Dabur India 376.8  [ 1.29% ]  DLF 659.7  [ 0.50% ]  Dr. Reddy's Lab. 1138.5  [ -0.41% ]  GAIL (India) 173.8  [ -0.69% ]  Grasim Industries 3310.05  [ 0.09% ]  HCL Technologies 1205.05  [ -1.75% ]  HDFC Bank 693.3  [ 0.88% ]  Hero MotoCorp 5242  [ 0.08% ]  Hindustan Unilever 1942.2  [ -0.14% ]  Hindalco Industries 1011.4  [ -1.33% ]  ICICI Bank 1382.5  [ -0.55% ]  Indian Hotels Co. 717.6  [ -0.61% ]  IndusInd Bank 990  [ -1.20% ]  Infosys 1031.5  [ -0.34% ]  ITC 260.5  [ -0.27% ]  Jindal Steel 1135  [ -1.09% ]  Kotak Mahindra Bank 413.9  [ -0.12% ]  L&T 3929.45  [ 0.11% ]  Lupin 2082.4  [ -0.46% ]  Mahi. & Mahi 3129.1  [ -0.66% ]  Maruti Suzuki India 12629.15  [ 0.01% ]  MTNL 25.14  [ -0.28% ]  Nestle India 1384.4  [ -0.62% ]  NIIT 94.3  [ -0.53% ]  NMDC 84.24  [ -1.59% ]  NTPC 334.25  [ 0.30% ]  ONGC 236.2  [ 1.03% ]  Punj. NationlBak 116.65  [ 0.91% ]  Power Grid Corpn. 271  [ 1.90% ]  Reliance Industries 1273  [ -0.62% ]  SBI 1005.6  [ 0.40% ]  Vedanta 270.6  [ -1.17% ]  Shipping Corpn. 284.7  [ -0.90% ]  Sun Pharmaceutical 1849.5  [ -1.02% ]  Tata Chemicals 610.7  [ 1.29% ]  Tata Consumer 999.35  [ -0.41% ]  Tata Motors Passenge 302.25  [ -0.48% ]  Tata Steel 185.7  [ -1.51% ]  Tata Power Co. 366.6  [ -0.65% ]  Tata Consult. Serv. 2198.95  [ -0.45% ]  Tech Mahindra 1516  [ 0.92% ]  UltraTech Cement 10933  [ 0.34% ]  United Spirits 1411.65  [ 0.53% ]  Wipro 166.4  [ -0.66% ]  Zee Entertainment 81.38  [ -5.06% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    NEULAND LABORATORIES LTD.

    10 September 2026 | 01:39

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE794A01010 BSE Code / NSE Code 524558 / NEULANDLAB Book Value (Rs.) 1,576.07 Face Value 10.00
    Bookclosure 24/07/2026 52Week High 24225 EPS 283.71 P/E 84.72
    Market Cap. 30836.64 Cr. 52Week Low 11500 P/BV / Div Yield (%) 15.25 / 0.14 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Neuland Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Neuland Laboratories Ltd. 641.58 776.25 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Neuland Laboratories Ltd. 8.49 12.46 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Neuland Laboratories Ltd. 196.02 281.82 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Neuland Laboratories Ltd. 147.36 212.52 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Neuland Laboratories Ltd. 12.90 12.90 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Neuland Laboratories Ltd. 30.55 36.30 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Neuland Laboratories Ltd. 22.96 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Neuland Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Neuland Laboratories Ltd. 2022.99 1476.84 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Neuland Laboratories Ltd. 573.25 322.30 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Neuland Laboratories Ltd. 30.16 20.51 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Neuland Laboratories Ltd. 487.73 268.97 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Neuland Laboratories Ltd. 363.10 259.43 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Neuland Laboratories Ltd. 12.90 12.90 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Neuland Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Neuland Laboratories Ltd. 1852.11 1504.05 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Neuland Laboratories Ltd. 196.61 136.01 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Neuland Laboratories Ltd. 865.87 524.37 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Neuland Laboratories Ltd. 1176.91 954.89 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Neuland Laboratories Ltd. 2.14 109.37 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Neuland Laboratories Ltd. 1538.70 1066.25 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Neuland Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Neuland Laboratories Ltd. 28.33 21.82 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Neuland Laboratories Ltd. 17.94 17.56 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Neuland Laboratories Ltd. 283.01 202.20 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Neuland Laboratories Ltd. 19.46 17.10 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Neuland Laboratories Ltd. 0.10 0.08 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Neuland Laboratories Ltd. 25.20 41.32 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Neuland Laboratories Ltd. 1.78 2.03 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Neuland Laboratories Ltd. 34.00 12.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute